NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome

NCT07278492 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Down Syndrome (DS)

Interventions

DRUG: MIB-626
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]